• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血管活性肠肽原包含一种新的类PHI-27肽,即PHM-27。

Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27.

作者信息

Itoh N, Obata K, Yanaihara N, Okamoto H

出版信息

Nature. 1983;304(5926):547-9. doi: 10.1038/304547a0.

DOI:10.1038/304547a0
PMID:6571696
Abstract

Vasoactive intestinal polypeptide (VIP), a 28-amino acid peptide originally isolated from porcine duodenum, is present not only in gastrointestinal tissues but also in neural tissues, possibly as a neurotransmitter, and exhibits a wide range of biological actions (for example, relaxation of smooth muscle, stimulation of intestinal water and electrolyte secretion and release of insulin, glucagon and several anterior pituitary hormones). As the structure of porcine and bovine VIP shows several similarities to those of mammalian glucagon, secretin and gastric inhibitory peptide (GIP), VIP is considered to be a member of the glucagon-secretin family. Recently, we have found that VIP is synthesized from a precursor, pro-VIP (molecular weight (Mr) 17,500), in human neuroblastoma cells and that the primary translation product of the mRNA encoding VIP is prepro-VIP (Mr 20,000). In an attempt to elucidate the primary structure of the precursor, we have now cloned the DNA sequence complementary to the mRNA coding for human VIP and analysed the nucleotide sequence. The entire amino acid sequence of the precursor, deduced from the nucleotide sequence, indicates that the precursor protein contains not only VIP but also a novel peptide of 27 amino acids. The peptide, designated PHM-27, differs by only 2 amino acids from PHI-27, a peptide recently isolated from porcine intestine, and is also closely related in sequence to VIP.

摘要

血管活性肠肽(VIP)是一种最初从猪十二指肠中分离出来的由28个氨基酸组成的肽,它不仅存在于胃肠道组织中,也存在于神经组织中,可能作为一种神经递质,并具有广泛的生物学作用(例如,使平滑肌松弛、刺激肠道水和电解质分泌以及释放胰岛素、胰高血糖素和几种垂体前叶激素)。由于猪和牛的VIP结构与哺乳动物的胰高血糖素、促胰液素和胃抑肽(GIP)有一些相似之处,因此VIP被认为是胰高血糖素-促胰液素家族的成员。最近,我们发现VIP是在人神经母细胞瘤细胞中由前体前血管活性肠肽(分子量(Mr)17,500)合成的,并且编码VIP的mRNA的初级翻译产物是前原血管活性肠肽(Mr 20,000)。为了阐明该前体的一级结构,我们现在克隆了与编码人VIP的mRNA互补的DNA序列并分析了核苷酸序列。从核苷酸序列推导出来的前体的完整氨基酸序列表明,该前体蛋白不仅包含VIP,还包含一种由27个氨基酸组成的新肽。该肽被命名为PHM - 27,与最近从猪肠道中分离出来的肽PHI - 27仅相差2个氨基酸,并且在序列上也与VIP密切相关。

相似文献

1
Human preprovasoactive intestinal polypeptide contains a novel PHI-27-like peptide, PHM-27.人血管活性肠肽原包含一种新的类PHI-27肽,即PHM-27。
Nature. 1983;304(5926):547-9. doi: 10.1038/304547a0.
2
Tissue-specific alternative splicing of turkey preprovasoactive intestinal peptide messenger ribonucleic acid, its regulation, and correlation with prolactin secretion.火鸡前血管活性肠肽信使核糖核酸的组织特异性可变剪接、其调控以及与催乳素分泌的相关性。
Endocrinology. 1995 Jun;136(6):2602-10. doi: 10.1210/endo.136.6.7750483.
3
Nucleotide sequence divergence and functional constraint in VIP precursor mRNA evolution between human and rat.人与大鼠之间血管活性肠肽前体mRNA进化中的核苷酸序列差异与功能限制
FEBS Lett. 1985 Apr 8;183(1):55-9. doi: 10.1016/0014-5793(85)80953-4.
4
Complete nucleotide sequence of human vasoactive intestinal peptide/PHM-27 gene and its inducible promoter.人血管活性肠肽/PHM-27基因及其诱导型启动子的完整核苷酸序列
Ann N Y Acad Sci. 1988;527:87-102. doi: 10.1111/j.1749-6632.1988.tb26975.x.
5
Cyclic AMP regulation of pro-vasoactive intestinal polypeptide/PHM-27 synthesis in human neuroblastoma cells.环磷酸腺苷对人神经母细胞瘤细胞中血管活性肠肽前体/PHM-27合成的调节
J Biol Chem. 1984 Jul 25;259(14):9207-11.
6
The glucagon superfamily: precursor structure and gene organization.胰高血糖素超家族:前体结构与基因组织
Peptides. 1986;7 Suppl 1:27-36. doi: 10.1016/0196-9781(86)90160-9.
7
Structure of the human vasoactive intestinal polypeptide gene.人类血管活性肠肽基因的结构
DNA. 1985 Aug;4(4):293-300. doi: 10.1089/dna.1985.4.293.
8
Structure and expression of the gene encoding the vasoactive intestinal peptide precursor.血管活性肠肽前体编码基因的结构与表达
Proc Natl Acad Sci U S A. 1987 Jan;84(2):605-9. doi: 10.1073/pnas.84.2.605.
9
Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptide.
Eur J Biochem. 1988 Dec 15;178(2):343-50. doi: 10.1111/j.1432-1033.1988.tb14456.x.
10
Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome.血管活性肠肽和PHM-27肽的编码序列位于人类基因组的两个相邻外显子上。
Proc Natl Acad Sci U S A. 1985 Jun;82(11):3548-51. doi: 10.1073/pnas.82.11.3548.

引用本文的文献

1
Pressure-Dependent Elevation of Vasoactive Intestinal Peptide Level in Chicken Choroid.鸡脉络膜中血管活性肠肽水平的压力依赖性升高
Biology (Basel). 2023 Mar 24;12(4):495. doi: 10.3390/biology12040495.
2
Vasoactive Intestinal Peptide (VIP) Protects Nile Tilapia () against Infection.血管活性肠肽(VIP)可保护尼罗罗非鱼()抵抗感染。
Int J Mol Sci. 2022 Nov 28;23(23):14895. doi: 10.3390/ijms232314895.
3
Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes.血管活性肠肽及其受体 VPAC2 在 2 型糖尿病中的治疗潜力。
Front Endocrinol (Lausanne). 2022 Sep 20;13:984198. doi: 10.3389/fendo.2022.984198. eCollection 2022.
4
The role of exome sequencing in childhood interstitial or diffuse lung disease.外显子组测序在儿童间质性或弥漫性肺部疾病中的作用。
Orphanet J Rare Dis. 2022 Sep 9;17(1):350. doi: 10.1186/s13023-022-02508-1.
5
Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors.靶向 VIP 和 PACAP 受体信号:设计 PACAP 受体亚家族药物的新见解。
Int J Mol Sci. 2022 Jul 22;23(15):8069. doi: 10.3390/ijms23158069.
6
Signal Transduction by VIP and PACAP Receptors.血管活性肠肽和垂体腺苷酸环化酶激活肽受体介导的信号转导
Biomedicines. 2022 Feb 9;10(2):406. doi: 10.3390/biomedicines10020406.
7
VIP/PACAP signaling as an alternative target during hyperoxic exposure in preterm newborns.VIP/PACAP 信号作为早产儿高氧暴露时的替代靶标。
Physiol Res. 2021 Aug 31;70(4):489-499. doi: 10.33549/physiolres.934638. Epub 2021 Jun 1.
8
Recent advances in vasoactive intestinal peptide physiology and pathophysiology: focus on the gastrointestinal system.血管活性肠肽生理与病理生理学的最新进展:聚焦于胃肠系统
F1000Res. 2019 Sep 12;8. doi: 10.12688/f1000research.18039.1. eCollection 2019.
9
Do Neuroendocrine Peptides and Their Receptors Qualify as Novel Therapeutic Targets in Osteoarthritis?神经内分泌肽及其受体是否可作为骨关节炎的新型治疗靶点?
Int J Mol Sci. 2018 Jan 26;19(2):367. doi: 10.3390/ijms19020367.
10
Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases.炎症、疼痛和神经退行性疾病中的神经肽与小胶质细胞激活
Mediators Inflamm. 2017;2017:5048616. doi: 10.1155/2017/5048616. Epub 2017 Jan 5.